Lipoprotein Lipid Abnormalities in Healthy Renal Transplant Recipients: Persistence of Low HDL2 Cholesterol
- 1 January 1987
- journal article
- research article
- Published by S. Karger AG in Nephron
- Vol. 47 (1) , 17-21
- https://doi.org/10.1159/000184450
Abstract
There is disagreement about the prevalence and character of lipoprotein lipid abnormalities in renal transplant patients. To test the hypothesis that these abnormalities may be related to the coexistence of medical conditions and medications which affect lipoprotein metabolism in these patients, triglyceride (TG), cholesterol (C), high-density lipoprotein (HDL) and HDL-C subfractions were measured in 26 transplanted patients (10 F/16 M), control subjects matched for age, sex, weight and race and uremic patients being treated with hemodialysis. Female transplant recipients had higher TG (181 ± 47 vs. 68 ± 6 mg/dl; p < 0.001), C (242 ± 19 vs. 165 ± 9 mg/dl; p < 0.01), and low-density lipoprotein (LDL)-C (155 ± 15 vs. 93 ± 8 mg/dl; p < 0.01) than controls. Levels of HDL-C were similar, but HDL2 was significantly lower in the transplanted patients (9 ± 2 vs. 19 ± 2 mg/dl; p < 0.01). Compared to the uremic patients, female transplanted patients had higher C (242 ± 19 vs. 178 ± 22 mg/dl; p < 0.01), LDL-C (155 ± 15 vs. 94 ± 18 mg/dl; p < 0.01), HDL-C (51 ± 5 vs. 32 ± 4 mg/dl; p < 0.001) and HDL3-C (42 ± 4 vs. 26 ± 2 mg/dl; p < 0.001); however, HDL2-C levels were not significantly different. Similarly, male transplanted patients had higher TG (166 ± 26 vs. 100 + 12 mg/dl; p < 0.01), C (213 ± 10 vs. 158 ± 3 mg/dl; p < 0.01), LDL-C (126 ± 9 vs. 97 ± 3 mg/dl; p < 0.05) and HDL-C (54 ± 4 vs. 41 ± 3 mg/dl; p < 0.05) than controls and higher HDL (54 ± 4 vs. 36 ± 4 mg/dl; p < 0.05) and HDL3 (47 ± 3 vs. 30 ± 2 mg/dl; p < 0.05) than uremic patients. However, HDL2-C levels did not differ among the transplanted, control or uremic groups. Thus, both male and female renal transplant recipients who are otherwise healthy have elevated plasma TG, C and LDL-C and normal to high levels of HDL-C; however their HDL2-C levels are low. These abnormalities may explain why renal transplant recipients have an increased incidence of atherosclerotic vascular disease.Keywords
This publication has 12 references indexed in Scilit:
- Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemiaJAMA, 1983
- Plasma Lipoproteins, Lipolytic Enzymes, and Very Low Density Lipoprotein Triglyceride Turnover in Cushing’s Syndrome*Journal of Clinical Endocrinology & Metabolism, 1983
- Effect of alternate-day prednisone on plasma lipids in renal transplant recipientsKidney International, 1982
- High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjectsMetabolism, 1982
- Origin and pattern of glucocorticoid-induced hyperlipidemia in rats dose-dependent bimodal changes in serum lipids and lipoproteins in relation to hepatic lipogenesis and tissue lipoprotein lipase activityBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- EFFECT OF PREDNISONE DOSE SPACING ON PLASMA-LIPIDS1980
- Hyperlipidemia After Renal Transplantation: Natural History and PathophysiologyAnnals of Internal Medicine, 1979
- Hyperlipidemia in adult, pediatric and diabetic renal transplant recipientsThe American Journal of Medicine, 1978
- Lipid Disorders in Renal Transplant RecipientsNephron, 1978
- Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant PatientsNew England Journal of Medicine, 1977